Abstract
Th17 cells contribute to several inflammatory conditions and increasing evidence supports that Th17 cells are glucocorticoid resistant. However, Th17 cells in psoriasis and related diseases are glucocorticoid sensitive. We compare glucocorticoid sensitive and resistant immunological diseases and suggest that several aspects in Th17-related diseases alter glucocorticoid sensitivity of Th17 cells. We identify molecular pathways that are implicated in glucocorticoid sensitivity of Th17 cells in the literature, as this information is useful for developing approaches to overcome glucocorticoid-resistant immunopathology.
Original language | English (US) |
---|---|
Pages (from-to) | 331-341 |
Number of pages | 11 |
Journal | Allergy: European Journal of Allergy and Clinical Immunology |
Volume | 72 |
Issue number | 3 |
DOIs | |
State | Published - Mar 1 2017 |
Funding
This study was funded by the National Institute of Allergy and Infectious Diseases, (R21AI113935), National Heart, Lung, and Blood Institute (R37HL068546), and the Ernest S. Bazley Foundation.
Keywords
- Th17 cells
- asthma
- autoimmunity
- glucocorticoid resistance
- glucocorticoids
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology